TASC commercial portfolio

Tayside has continued commitment to delivery and performance in an environment where the study mix is becoming more challenging and labour-intensive.

On this page

Studies in Tayside

Tayside has taken part in 174 commercial research studies in the past 5 years (2015-2020)

     Our Tayside studies were in the following categories:

    • 70% drug trials
    • 10% questionnaire studies
    • 8% medical device trials
    • 8% limited to data
    • 4% basic science and qualitative studies
    TASC A pie chart indicating the percentage and types of research studies taken in Tayside

    Active therapy areas

    Our most active therapy areas are:

    • Cancer 24%
    • Neuroprogressive and Dementia 18%
    • Cardiovascular 14%
    • Dermatology 10%
    • Respiratory 9%
    • Diabetes 8%
    • and Paediatrics 6%
    A pie chart showing the percentage of active therapy areas

    Study recruitment

    We recruited 994 participants to trials in Tayside.

    57% of our studies recruited to target and 24% over recruited (2018-2020)

    A pie chart showing the percentage of our studies recruited to target and percentage over recruited